Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Enlyte Celebrates National Adjuster Day With Clinician-Reviewed Medical Records Tool to Ease Claims Burden
Adjusters are often considered the foundation of insurance industry success, but their vital role is often underappreciated. So, once again, Enlyte is celebrating these professionals in honor of National Adjuster Day, Aug. 17, by launching another product designed to make their lives easier.
Specialty Solutions Spotlight: How Physical Therapy Clinical Guidelines Help Drive Faster Recovery and Lower Claim Costs
Physical therapy (PT) plays a central role in recovery. But without clear targets, treatment can easily extend longer than necessary, delaying return to work and increasing costs. That’s where clinical guidelines come in. They provide benchmarks for treatment progression, expected visit counts, and documentation standards—all critical elements needed to ensure appropriate care, reduce friction, and keep claims moving forward.
Delivering The Most-Favored Nation Prescription Drug Pricing to American Patients
Why are U.S. prescription drug prices so much higher than in other developed nations—and what is the government doing about it? A new executive order from the White House could shake up how brand-name drugs are priced and reimbursed, with potential ripple effects across auto and workers’ comp. But is it really a game-changer, or just another attempt at reducing drug costs? Brian Allen, VP of Government Affairs breaks down the executive order and what it could mean for work comp and auto.
Ask The Pharmacist: The Role of Topical Medications in Workers’ Compensation
Topical analgesics—medications applied directly to the skin—are commonly used to manage pain in workers’ compensation claims involving injuries like sprains, strains or muscle aches. While these medications offer targeted relief and are often seen as safer alternatives to opioids, they also present rising cost concerns.
Turn Complexity into Progress: Four Steps to Mastering Specialty Services
In this quick-read guide, you’ll discover how top-performing teams are simplifying fragmented processes to deliver faster, more cost-effective care.
Automate the Chaos: AI, Dashboards, and the Future of Claims
See how data, connected systems, and analytics can help you close claims faster, cut errors, and prevent costly delays.